Author:
Legnani Federico G.,Pradilla Gustavo,Thai Quoc-Anh,Fiorindi Alessandro,Recinos Pablo F.,Tyler Betty M.,Gaini Sergio M.,DiMeco Francesco,Brem Henry,Olivi Alessandro
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Neurology (clinical),Neurology,Oncology
Reference36 articles.
1. Fenteany G, Standaert RF, Lane WS, Choi S, Corey EJ and Schreiber SL (1995). Inhibition of proteasome activities and subunit-specific amino-terminal threonine modification by lactacystin. Science 268: 726–731
2. King RW, Deshaies RJ, Peters JM and Kirschner MW (1996). How proteolysis drives the cell cycle. Science 274: 1652–1659
3. An B, Goldfarb RH, Siman R and Dou QP (1998). Novel dipeptidyl proteasome inhibitors overcome Bcl-2 protective function and selectively accumulate the cyclin-dependent kinase inhibitor p27 and induce apoptosis in transformed, but not normal, human fibroblasts. Cell Death Differ 5: 1062–1075
4. Masdehors P, Merle-Beral H, Maloum K, Omura S, Magdelenat H and Delic J (2000). Deregulation of the ubiquitin system and p53 proteolysis modify the apoptotic response in B-CLL lymphocytes. Blood 96: 269–274
5. Orlowski RZ, Eswara JR, Lafond-Walker A, Grever MR, Orlowski M and Dang CV (1998). Tumor growth inhibition induced in a murine model of human Burkitt’s lymphoma by a proteasome inhibitor. Cancer Res 58: 4342–4348
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献